Get started Log in

HYL — Hyloris Pharmaceuticals SA Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
€108.08m
Enterprise Value
€100.44m
Revenue
€7.21m

Brief: Hyloris Pharmaceuticals Says AFT Signed Exclusive License And Supply Agreements For Commercialisation Of Maxigesic IV
08/04/2021 06:11
Corrected: BRIEF-Euronext Announces Annual Revision Of Belgian Indices
10/03/2021 17:37
Brief: Hyloris Pharmaceuticals FY Net Loss Widens To EUR 7.1 Mln
09/03/2021 06:08
Brief: Hyloris, PFH Partner To Develop Vulvovaginal Candidiasis Product
05/02/2021 06:11
Brief: Hyloris Pharmaceuticals: Distribution Agreements For Maxigesic IV In UK And Hong Kong
04/11/2020 08:15
Brief: Hyloris Announces Approval Of Maxigesic® IV In Eight European Countries
07/09/2020 10:10
Brief: Hyloris Pharmaceuticals H1 Operating Loss Widens To 3.6 Million Euros
06/08/2020 07:33